Image Cited: Unsplash
Bitnomial has launched monthly futures tied to Injective’s (INJ) token, giving the asset its first US-regulated derivatives market. The contracts began trading on April 15 on Bitnomial Exchange, a CFTC-regulated designated contract market, and are cleared through Bitnomial Clearinghouse.
The launch matters beyond a single token listing. In the US crypto market, regulated futures do more than open a new trading venue. They also create the price history, surveillance record and market structure that exchanges and issuers can use when trying to bring exchange-traded products to market.
The contract gives INJ a regulated trading lane
Bitnomial said the INJ contracts are crypto-settled, have monthly expirations and allow traders to post either crypto or US dollars as margin through its clearinghouse. Access will initially run through Bitnomial Exchange clearing member futures commission merchants, with retail access on the company’s Botanical platform expected in the coming weeks.
That gives Injective something it did not have before: a US venue where regulated participants can trade futures on the token under CFTC oversight. The contract was certified with the CFTC on April 6, and the agency’s product filings now list Bitnomial’s Injective US Dollar Centi Futures as a certified futures product.
The ETF angle is now part of the story
Bitnomial has been open about the broader goal. In its own market commentary, the exchange said the SEC’s 2025 generic listing standards shortened crypto ETP timelines, but that regulated futures markets on designated contract markets are now an important part of the path for tokens seeking ETF treatment.
Injective has already come close to that process. Canary Capital filed for a staked INJ ETF last year, though the related Cboe BZX rule change was withdrawn on March 9. A live US-regulated futures market does not guarantee approval, but it gives future applicants a stronger surveillance and price discovery base than INJ had before this week.
Bitnomial is widening its crypto product lineup
For Bitnomial, the launch adds another digital asset contract to a business that has been pushing further into the regulated crypto market infrastructure. The company says its futures platform is built around physically delivered crypto products, and INJ now joins Bitnomial’s existing lineup of crypto futures, which includes Bitcoin, XRP, and Aptos. For Injective, the result is straightforward: a regulated U.S. venue and a better base for future ETF applications.
